Data suggest that obesity can trigger numerous immune-inflammatory pathways associated with PsA development
In 2023, Fractyl Heath announced mice given semaglutide and treated with its gene therapy Rejuva, administered directly to the pancreas, had maintained a 22% weight loss for 28 weeks after stopping the drug and performed better than those given only semaglutide
GLP-1 is a modern, non-surgical option that supports your bodys natural ability to feel full and stay satisfied longer
Additionally, DietWorks GLP-1 Companion offers a comprehensive gut health boost with a blend of probiotics and herbal ingredients that support digestion and nutrient absorption
Research suggests that patients who stop medication often regain weight unless they have established sustainable lifestyle habits during treatment
This combination of a manageable safety profile and an ethical trial design that prioritizes patient outcomes is encouraging for future clinical adoption and real-world application
